Evidence map›Paper›PMID 28956772›Full record

ReviewCirculation. Cardiovascular imaging2017

Machine Learning Approaches in Cardiovascular Imaging.

Mir Henglin, Gillian Stein, Pavel V Hushcha, Jasper Snoek, Alexander B Wiltschko, Susan Cheng

Abstract readReview
In one paragraph

Review in Circulation. Cardiovascular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Artificial Intelligence in Diagnosis of Heart Failure.Journal of the American Heart Association · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mir HenglinFrom the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.H., G.S., P.V.H., S.C.); Google Brain, Google Inc, Cambridge, MA (J.S., A.W.); and Framingham Heart Study, MA (S.C.). scheng@rics.bwh.harvard.edu.
Gillian SteinFrom the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.H., G.S., P.V.H., S.C.); Google Brain, Google Inc, Cambridge, MA (J.S., A.W.); and Framingham Heart Study, MA (S.C.).
Pavel V HushchaFrom the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.H., G.S., P.V.H., S.C.); Google Brain, Google Inc, Cambridge, MA (J.S., A.W.); and Framingham Heart Study, MA (S.C.).
Jasper SnoekFrom the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.H., G.S., P.V.H., S.C.); Google Brain, Google Inc, Cambridge, MA (J.S., A.W.); and Framingham Heart Study, MA (S.C.).
Alexander B WiltschkoFrom the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.H., G.S., P.V.H., S.C.); Google Brain, Google Inc, Cambridge, MA (J.S., A.W.); and Framingham Heart Study, MA (S.C.).
Susan ChengFrom the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.H., G.S., P.V.H., S.C.); Google Brain, Google Inc, Cambridge, MA (J.S., A.W.); and Framingham Heart Study, MA (S.C.).

Funding

Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2R01HL131532 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHENG, SUSAN, LI, DEBIAO · 2016 to 2025
$6.6M
Inflammatory Mediators, Cardiovascular Health, and Longevity in WomenR01HL134168 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHENG, SUSAN · 2016 to 2019
$1.6M
NHLBI NIH HHS R01 HL131532NHLBI NIH HHS R01 HL134168
6 · The paper itself

Abstract

Cardiovascular imaging technologies continue to increase in their capacity to capture and store large quantities of data. Modern computational methods, developed in the field of machine learning, offer new approaches to leveraging the growing volume of imaging data available for analyses. Machine learning methods can now address data-related problems ranging from simple analytic queries of existing measurement data to the more complex challenges involved in analyzing raw images. To date, machine learning has been used in 2 broad and highly interconnected areas: automation of tasks that might otherwise be performed by a human and generation of clinically important new knowledge. Most cardiovascular imaging studies have focused on task-oriented problems, but more studies involving algorithms aimed at generating new clinical insights are emerging. Continued expansion in the size and dimensionality of cardiovascular imaging databases is driving strong interest in applying powerful deep learning methods, in particular, to analyze these data. Overall, the most effective approaches will require an investment in the resources needed to appropriately prepare such large data sets for analyses. Notwithstanding current technical and logistical challenges, machine learning and especially deep learning methods have much to offer and will substantially impact the future practice and science of cardiovascular imaging.

Indexed as

Machine LearningAlgorithmsAutomationCardiovascular DiseasesDiagnostic ImagingHumansImage Interpretation, Computer-AssistedPredictive Value of TestsPrognosisReproducibility of ResultsSeverity of Illness IndexWorkflowalgorithmsartificial intelligenceautomationworkflow

Identifiers

PMID28956772
PMCPMC5718356

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.